GI
CERE

GAMMA Investing’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

GAMMA Investing’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$164 – 3669
2024
Q2 		$164 Hold
4
– – ﹤0.01% 3375
2024
Q1 		$169 Buy
+4
New +$168 ﹤0.01% 3242

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

GAMMA Investing's CERE Position: Q3 2024 in Review

GAMMA Investing sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 4 shares — an estimated $164 sold.

GAMMA Investing first reported a position in CERE in Q1 2024 and held it in 2 quarters. The position peaked at $169 in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • GAMMA Investing reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • GAMMA Investing sold 4 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $164.
  • GAMMA Investing first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • GAMMA Investing's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $169 in Q1 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on GAMMA Investing's 13F filing for Q3 2024, filed 7 Oct 2024.